This cell-like structure can grow, feed, divide and compete. Researchers ponder what it means for the future of synthetic ...
The Council has agreed its position on a proposed directive that updates the rules on genetically modified micro-organisms ...
Humanmaxxing is the latest wellness trend focused on maximizing human potential through biohacking, longevity science and ...
SpaceX has officially requested FCC approval to launch and operate a third-generation satellite constellation of 100,000 satellites, designed to power human ...
AtaiBeckley doses last patient in Elumina, phase 2b trial of VLS-01 in adults with treatment-resistant depression: New York Tuesday, July 7, 2026, 10:00 Hrs [IST] AtaiBeckley Inc.
In September, 23-year old Bella Ramirez will become the first person in her family to attend graduate school, after ...
The airwaves are crackling this week with news of the first synthetic cell, constructed and cultured by researchers from the ...
Detailed price information for Nasdaq Biotechnology Ishares ETF (IBB-Q) from The Globe and Mail including charting and trades ...
Biopharmaceutical developers should introduce risk-based, phase-appropriate characterization strategies for quality control ...
IMU Biosciences partners with Waters to advance IMU’s AI-driven immunology platform to transform diagnosis and monitoring: London, UK Friday, June 26, 2026, 12:00 Hrs [IST] IMU ...
Industry groups are asking the US Food and Drug Administration (FDA) for greater transparency into its Commissioner's National Priority Voucher (CNPV) pilot, including how the agency intends to ...
Waters Corporation (NYSE: WAT) and IMU Biosciences, a biotechnology company decoding the immune system to pioneer a paradigm shift in how we understand, diagnose, and treat disease, today announced a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results